During the last session, Revolution Medicines Inc. (NASDAQ:RVMD)’s traded shares were 0.53 million. At the end of the trading day, the stock’s price was $23.30, reflecting an intraday loss of -0.26% or -$0.06. The 52-week high for the RVMD share is $34.16, that puts it down -46.61 from that peak though still a striking 39.57% gain since the share price plummeted to a 52-week low of $14.08. The company’s market capitalization is $1.72B, and the average intraday trading volume over the past 10 days was 0.6 million shares, and the average trade volume was 757.22K shares over the past three months.
Revolution Medicines Inc. (RVMD) received a consensus recommendation of an Overweight from analysts. That translates to a mean rating of 1.90. RVMD has a Sell rating from 0 analyst(s) out of 8 analysts who have looked at this stock. 3 analyst(s) recommend to Hold the stock while 0 suggest Overweight, and 5 recommend a Buy rating for it. 0 analyst(s) has rated the stock Underweight. Company’s earnings per share (EPS) for the current quarter are expected to be -$0.85.
3 Tiny Stocks Primed to Explode The world’s greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We’ve set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Revolution Medicines Inc. (RVMD) registered a -0.26% downside in the last session and has traded in the red over the past 5 sessions. The stock plummet -0.26% in intraday trading to $23.30 this Friday, 07/15/22, hitting a weekly high. The stock’s 5-day price performance is -0.47%, and it has moved by 38.61% in 30 days. Based on these gigs, the overall price performance for the year is -20.45%. The short interest in Revolution Medicines Inc. (NASDAQ:RVMD) is 7.71 million shares and it means that shorts have 11.52 day(s) to cover.
The consensus price target of analysts on Wall Street is $30.00, which implies an increase of 22.33% to the stock’s current value. The extremes of the forecast give a target low and a target high price of $19.00 and $40.00 respectively. As a result, RVMD is trading at a discount of -71.67% off the target high and 18.45% off the low.
Revolution Medicines Inc. (RVMD) estimates and forecasts
Statistics show that Revolution Medicines Inc. has underperformed its competitors in share price, compared to the industry in which it operates. Revolution Medicines Inc. (RVMD) shares have gone down -6.35% during the last six months, with a year-to-date growth rate less than the industry average at -39.30% against 11.20. Yet analysts are ramping up their growth forecast for the fiscal year 2022. Revenue is predicted to shrink -41.70% this quarter and then drop -23.60% in the quarter after that. In the rating firms’ projections, revenue will increase 2.70% compared to the previous financial year.
Revenue for the current quarter is expected to be $6.65 million as predicted by 7 analyst(s). Meanwhile, a consensus of 7 analyst(s) estimates revenue growth to $6.65 million by the end of Sep 2022. As per earnings report from last fiscal year’s results, sales for the corresponding quarters totaled $8.7 million and $1.1 million respectively. In this case, analysts expect current quarter sales to shrink by -23.50% and then jump by 504.00% in the coming quarter.
While earnings are projected to return -27.80% in 2022.
Revolution Medicines Inc. is due to release its next quarterly earnings between February 28 and March 04. However, it is important to remember that the dividend yield ratio is merely an indicator meant to only serve as guidance.
Revolution Medicines Inc. (NASDAQ:RVMD)’s Major holders
Revolution Medicines Inc. insiders own 1.65% of total outstanding shares while institutional holders control 97.26%, with the float percentage being 98.90%. Vanguard Group, Inc. (The) is the largest shareholder of the company, while 201 institutions own stock in it. As of Dec 30, 2021, the company held over 6.3 million shares (or 8.48% of all shares), a total value of $158.56 million in shares.
The next largest institutional holding, with 6.1 million shares, is of FMR, LLC’s that is approximately 8.22% of outstanding shares. At the market price on Dec 30, 2021, these shares were valued at $153.58 million.
Also, the Mutual Funds coming in first place with the largest holdings of Revolution Medicines Inc. (RVMD) shares are Vanguard Total Stock Market Index Fund and SPDR (R) Ser Tr-SPDR (R) S&P (R) Biotech ETF. Data provided on Dec 30, 2021 indicates that Vanguard Total Stock Market Index Fund owns about 2.0 million shares. This amounts to just over 2.69 percent of the company’s overall shares, with a $50.22 million market value. The same data shows that the other fund manager holds slightly less at 1.84 million, or about 2.48% of the stock, which is worth about $39.67 million.